LABATE, Angelo
 Distribuzione geografica
Continente #
EU - Europa 3.696
NA - Nord America 2.820
AS - Asia 2.298
SA - Sud America 776
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 67
OC - Oceania 9
Totale 9.791
Nazione #
US - Stati Uniti d'America 2.689
RU - Federazione Russa 2.203
SG - Singapore 947
BR - Brasile 642
IE - Irlanda 517
HK - Hong Kong 413
CN - Cina 385
IT - Italia 328
SE - Svezia 250
VN - Vietnam 173
BD - Bangladesh 94
DE - Germania 83
FR - Francia 60
IN - India 56
CA - Canada 51
GB - Regno Unito 51
AR - Argentina 49
AT - Austria 42
MX - Messico 41
TR - Turchia 26
FI - Finlandia 24
IQ - Iraq 24
EC - Ecuador 22
PK - Pakistan 22
ID - Indonesia 21
NL - Olanda 21
PL - Polonia 21
CO - Colombia 19
ES - Italia 18
JP - Giappone 18
ZA - Sudafrica 18
UA - Ucraina 16
DZ - Algeria 15
DK - Danimarca 13
MY - Malesia 13
UZ - Uzbekistan 13
IL - Israele 11
MA - Marocco 11
VE - Venezuela 10
PY - Paraguay 9
TN - Tunisia 9
CL - Cile 8
CZ - Repubblica Ceca 7
KZ - Kazakistan 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
HN - Honduras 6
KG - Kirghizistan 6
LV - Lettonia 6
PA - Panama 6
PE - Perù 6
AM - Armenia 5
AU - Australia 5
CR - Costa Rica 5
GT - Guatemala 5
JM - Giamaica 5
JO - Giordania 5
KR - Corea 5
LT - Lituania 5
NI - Nicaragua 5
PH - Filippine 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
IR - Iran 4
KE - Kenya 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
EG - Egitto 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
AL - Albania 2
BB - Barbados 2
BE - Belgio 2
CI - Costa d'Avorio 2
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
MK - Macedonia 1
NG - Nigeria 1
Totale 9.658
Città #
Moscow 683
Dublin 517
Ashburn 446
Hong Kong 410
Singapore 379
Nyköping 230
San Jose 212
Dallas 187
Princeton 184
Medford 165
Chandler 136
The Dalles 105
Messina 104
Beijing 90
Los Angeles 89
São Paulo 63
Ho Chi Minh City 51
Santa Clara 49
New York 48
Hanoi 41
Nuremberg 36
Munich 31
Council Bluffs 25
Buffalo 24
Vienna 24
Tianjin 23
Redondo Beach 21
Milan 20
Lauterbourg 19
Orem 19
Bari 18
Shanghai 18
Tokyo 18
Brasília 17
Houston 17
Rio de Janeiro 17
Chennai 16
Brooklyn 15
Denver 15
Guangzhou 15
Mexico City 15
Warsaw 15
Chicago 14
Phoenix 14
Poplar 14
Palermo 13
Shenzhen 13
Belo Horizonte 12
Seattle 12
Amsterdam 11
Atlanta 11
Dhaka 11
Stockholm 11
Tashkent 11
Boston 10
Catania 10
Montreal 10
Rome 10
Brøndby 9
Florence 9
Frankfurt am Main 9
Johannesburg 9
Lappeenranta 9
Mumbai 9
Porto Alegre 9
Settimo Torinese 9
Toronto 9
Turku 9
Guarulhos 8
Haiphong 8
Querétaro 8
Salvador 8
San Francisco 8
Asunción 7
Da Nang 7
Guayaquil 7
London 7
Miami 7
Ankara 6
Bishkek 6
Campinas 6
Karachi 6
Kuala Lumpur 6
Manchester 6
Naples 6
Prague 6
Quito 6
Riga 6
Sorocaba 6
Baghdad 5
Bagheria 5
Baku 5
Boardman 5
Bogotá 5
Casablanca 5
Catanzaro 5
Cellamare 5
Hyderabad 5
Hải Dương 5
Jacksonville 5
Totale 5.100
Nome #
CPAP therapy improved sleep and reduced seizures in a young, obese epileptic woman with OSA 192
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 150
A case of frontal lobe seizures with ‘dancing-like’ semiology 149
The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus 148
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience 136
Management of status epilepticus in patients with liver or kidney disease: a narrative review 129
Genetics of reflex seizures and epilepsies in humans and animals 123
Human expressive movements: The boundary between health and disease from a contaminated perspective 118
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 116
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies 116
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide 114
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 111
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 110
Insight into epileptic and physiological déjà vu: from a multicentric cohort study 109
MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now? 108
SLEEP HYPERMOTOR EPILEPSY VS NREM PARASOMNIAS: A CHALLENGING CASE REPORT 106
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 106
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 106
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 105
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 103
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 103
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 101
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 98
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 98
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 97
Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? 97
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 97
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis 97
Binaural Beats Reduce Postoperative Morphine Consumption in Older adults After Total Knee Replacement Surgery 96
Adolescents with Neuropsychiatric Disorders during the COVID-19 Pandemic: Focus on Emotional Well-Being and Parental Stress. 95
Spectrum of epilepsy with eyelid myoclonia: Delineation of disease subtypes from a large multicenter study 94
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 92
Detection of hippocampal atrophy in patients with temporal lobe epilepsy: a 3-Tesla MRI shape 92
Diagnostic Biomarkers of Epilepsy 90
Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study 89
Failure to confirm association of a polymorphism in KCNMB4 gene with mesial temporal lobe epilepsy 88
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 88
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia 87
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis 87
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 87
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies 87
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 87
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia 85
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 85
Epilepsy and sleep disorders improve in adolescents and adults with Angelman syndrome: A multicenter study on 46 patients 85
Late drug-resistance in mild MTLE: Can it be influenced by preexisting white matter alterations? 85
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 84
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 84
Autosomal dominant lateral temporal epilepsy (ADLTE): absence of chromosomal rearrangements in LGI1 gene 82
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 82
Myoclonus: Differential diagnosis and current management 80
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 80
Profile of brivaracetam and its potential in the treatment of epilepsy 80
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 79
A puzzling case without solution: isolated late-onset epileptic seizure 79
Corticobulbar activity in healthy humans and Parkinson’s disease: a study protocol for a novel biomarker of motivational arousal 78
Epilepsy and Immune System: A Tour Around the Current Literature 78
Progressive myoclonus epilepsies—Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes 76
Family history and frontal lobe seizures predict long-term remission in newly diagnosed cryptogenic focal epilepsy 74
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 73
Structural network alterations in focal and generalized epilepsy follow axes of epilepsy risk gene expression: an enigma study. 72
Looking for indicative magnetic resonance imaging signs of hippocampal developmental abnormalities in patients with mesial temporal lobe epilepsy and healthy controls 72
Efficacy and safety of branded vs generic lacosamide in epilepsy: a retrospective real-world study 71
Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience 71
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data 71
Generalized versus partial reflex seizures: a review. 71
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 71
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to predict Drug Resistance in Temporal Lobe Epilepsy: a Pilot Study 69
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 67
Interpretable surface-based detection of focal cortical dysplasias: a MELD study. 67
Enlarging the clinical spectrum of chorea-acanthocytosis 65
Exercise-induced rhabdomyolysis as unusual manifestation of GLUT-1 Deficiency Syndrome 65
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 60
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 54
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 53
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 51
Utility of raw electroencephalography monitoring for estimating level of sedation in the perioperative setting 50
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 48
Relationship between genetic variant in pre-microRNA-146a and genetic predisposition to temporal lobe epilepsy: A case-control study 47
Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy 46
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 46
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 46
The efficacy of switching intravenous to oral brivaracetam following status epilepticus: A real-world, multicenter Sicilian study 45
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 45
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 44
ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy 43
Sleep effects in drug-resistant epileptic patients taking perampanel: an observational study 41
Benign mesial temporal lobe epilepsy 41
Juvenile Huntington's disease presenting as progressive myoclonic epilepsy 41
Usefulness of rectal biopsy for the diagnosis of Kufs disease: a controlled study and review of the literature 40
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness 39
Amygdala dysplasia with temporal lobe epilepsy and obsessive-compulsive disorder: An fMRI/EEG study 38
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features 38
Positivity to p-ANCA in patients with status epilepticus 38
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis 38
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 38
Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP 37
Typical childhood absence seizures are associated with thalamic activation 37
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 35
Babylonian knowledge about temporal lobe epilepsy: distinguishing mesial from lateral forms 34
Totale 7.996
Categoria #
all - tutte 36.440
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.440


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 0 1 0 3 0 0 1 1 2 5 2 349
2022/20231.145 193 103 54 7 12 65 51 21 604 4 29 2
2023/2024333 17 46 35 112 18 20 4 4 0 45 8 24
2024/20251.973 30 31 102 46 148 109 128 164 427 207 207 374
2025/20265.753 303 310 356 471 498 1.143 676 636 629 361 177 193
2026/2027202 192 10 0 0 0 0 0 0 0 0 0 0
Totale 9.791